Status:
COMPLETED
Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use
Lead Sponsor:
AstraZeneca
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
The purpose of the investigation is to confirm the following under the post-marketing actual use of Forxiga Tablets (hereinafter referred to as Forxiga) * Development of ADRs specified as Key Investi...
Eligibility Criteria
Inclusion
- Patients treated with Forxiga for the first time due to type 2 diabetes mellitus, which is the indication of the drug.
Exclusion
- N/A
Key Trial Info
Start Date :
October 3 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2019
Estimated Enrollment :
7793 Patients enrolled
Trial Details
Trial ID
NCT02200666
Start Date
October 3 2014
End Date
September 9 2019
Last Update
February 25 2020
Active Locations (47)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aichi, Japan, D1692C00014
2
Research Site
Akita, Japan, D1692C00014
3
Research Site
Aomori, Japan, D1692C00014
4
Research Site
Chiba, Japan, D1692C00014